Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-06-13

Clinical Trial Update: Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face [NA]

View source ↗

Summary

The MiMedx-sponsored clinical trial evaluating dehydrated human amnion/chorion membrane (dHACM) for recovery after fractionated ablative CO2 laser facial resurf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dehydrated Human Amnion/Chorion Membrane (dHACM) (dehydrated human amnion/chorion membrane)

Snippet

Sponsor: MiMedx Group, Inc. | Conditions: Scarring | NA | Status: WITHDRAWN